Therapeutic Area: Neurology Product Name: BAM Kit
Highest Development Status: Undisclosed Product Type: Small molecule
Partner/Sponsor/Collaborator: Wedgewood Pharmacy
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Acquisition August 10, 2020
ZooPharm’s BAM™ Kit includes a patented combination of Butorphanol tartrate, Azaperone tartrate, and Medetomidine hydrochloride that is used to immobilize a broad range of species.